Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-02-07 16:44:00 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1021/acs.jmedchem.5c03138
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03138
其他信息:
出版社: American Chemical Society (ACS)
作者: James S. Scott; Laura Evans; Peter C. Astles; Argyrides Argyrou; Sharan K. Bagal; David Beattie; Erin L. Braybrooke; Doyle J. Cassar; Claire Crafter; Coura Diène; Gary Fairley; Charlene Fallan; Graham Fraser; Nuria Galeano-Dalmau; Thomas G. Hammond; Andreas K. Hock; Thomas Jones; Jasper Komen; Gillian M. Lamont; Chrysiis Michaloglou; Michael J. Niedbala; Antonio Ramos-Montoya; Monica C. Rodrigo-Brenni; Martin J. Packer; Stuart Pearson; Andy Pike; Markus Schade; Joseph Shaw; Ziyanda Shologu; Oliver Steward
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03138
